{"id":7331,"date":"2021-07-27T11:49:21","date_gmt":"2021-07-27T06:19:21","guid":{"rendered":"https:\/\/www.seminarsonly.com\/news\/?p=7331"},"modified":"2021-07-27T14:50:18","modified_gmt":"2021-07-27T09:20:18","slug":"glenmark-pharmaceuticals-initial-public-offering","status":"publish","type":"post","link":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/","title":{"rendered":"Glenmark Pharmaceuticals \u2022 Initial public offering"},"content":{"rendered":"

Glenmark Pharmaceuticals \u2022 Initial public offering<\/span><\/h2>\n
\n

Related News<\/span><\/h2>\n

1. NDTV Profit<\/h3>\n
\n
<\/div>\n<\/div>\n
Glenmark Life Sciences IPO Opens Today<\/a><\/div>\n
NDTV Profit \u2022 2 hours ago<\/div>\n
<\/div>\n

2. Hindustan Times<\/h3>\n<\/div>\n
\n
\n
Glenmark Life Sciences IPO to open today: Check all details here<\/a><\/div>\n
<\/div>\n<\/div>\n
\n
Hindustan Times \u2022 5 hours ago<\/div>\n<\/div>\n<\/div>\n
\n
\n

3. Livemint<\/h3>\n
Glenmark Life IPO: GMP, subscription status and other details<\/a><\/div>\n
<\/div>\n<\/div>\n
\n
Livemint\u00a0\u2022\u00a038 minutes ago<\/div>\n<\/div>\n<\/div>\n

Google Most Searched Words Today 27 July 2021<\/span><\/h2>\n

1. West Indies vs Australia<\/h3>\n

LIVE Cricket Score, West Indies vs Australia 3rd ODI at Barbados …<\/p>\n

2. APJ Abdul Kalam<\/h3>\n

Abdul Kalam was born on October 15, 1931, at Rameshwaram in Tamil Nadu and died of cardiac arrest on July 27, 2015, while giving a lecture at the Indian<\/p>\n

3. Team 10m air pistol olympic games tokyo 2020<\/h3>\n

Tokyo Olympics LIVE: India Lovlina Borgohain took on Nadine Apetz of Germany in Preliminaries Round of 16 bout in women Welter (64-69kg) boxing event.<\/p>\n

4. AIIMS<\/h3>\n

TN cites formula to enrol 50 students for proposed Madurai AIIMS<\/p>\n

5. Ma Long<\/h3>\n

Nothing to lose, Sharath will go all out against Ma Long: Coach<\/p>\n

6. Uddhav Thackeray<\/h3>\n

Political analysts pointed out that Thackeray began to reshape his party since 2014, when he got fought the Assembly polls solo against the BJP<\/p>\n

7. Vijay Mallya<\/h3>\n

Fugitive Indian businessman Vijay Mallya was declared bankrupt on Monday by the Insolvency and Companies Court of the London high<\/p>\n

8. Tom Daley<\/h3>\n

A prodigy, a son missing his deceased father, a gay athlete who found love and safety in his Oscar-winning partner, a young father and now Olympic champion<\/p>\n

9. Abdul Kalam Quotes<\/h3>\n

APJ Abdul Kalam Death Anniversary: 20 Inspiring Quotes<\/p>\n

10. Angarki Chaturthi 2021<\/h3>\n

\u0938\u093e\u0935\u0928 \u092e\u093e\u0938 \u0915\u0940 \u0938\u0902\u0915\u0937\u094d\u091f\u0940 \u091a\u0924\u0941\u0930\u094d\u0925\u0940 \u0906\u091c \u0939\u0948\u0964 \u092f\u0939 \u0938\u0902\u0915\u0937\u094d\u091f\u0940 \u091a\u0924\u0941\u0930\u094d\u0925\u0940 \u092e\u0902\u0917\u0932\u0935\u093e\u0930 \u0915\u0947 \u0926\u093f\u0928 \u092a\u0921\u093c\u0940 \u0939\u0948 \u0907\u0938\u0932\u093f\u090f<\/p>\n","protected":false},"excerpt":{"rendered":"

Glenmark Pharmaceuticals \u2022 Initial public offering Related News 1. NDTV Profit Glenmark Life Sciences IPO Opens Today NDTV Profit \u2022 2 hours ago 2. Hindustan Times Glenmark Life Sciences IPO…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[2618,2619,2620,2616,2617],"class_list":["post-7331","post","type-post","status-publish","format-standard","hentry","category-news","tag-glenmark","tag-glenmark-ipo","tag-glenmark-life-sciences","tag-glenmark-life-sciences-ipo","tag-glenmark-life-sciences-ipo-gmp"],"yoast_head":"\nGlenmark Pharmaceuticals \u2022 Initial public offering - Seminarsonly.com<\/title>\n<meta name=\"description\" content=\"Glenmark Life Sciences share sale consists of a fresh issue of equities worth \u20b91,060 crore and an offer for sale by promoter Glenmark Pharmaceuticals for \u20b9453 crore.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glenmark Pharmaceuticals \u2022 Initial public offering\" \/>\n<meta property=\"og:description\" content=\"Glenmark Life Sciences share sale consists of a fresh issue of equities worth \u20b91,060 crore and an offer for sale by promoter Glenmark Pharmaceuticals for \u20b9453 crore.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/\" \/>\n<meta property=\"og:site_name\" content=\"Seminarsonly.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/seminarsonly\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-27T06:19:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-27T09:20:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg\" \/>\n<meta name=\"author\" content=\"Freddy John\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@seminarsonly\" \/>\n<meta name=\"twitter:site\" content=\"@seminarsonly\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Freddy John\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/\"},\"author\":{\"name\":\"Freddy John\",\"@id\":\"https:\/\/seminarsonly.com\/news\/#\/schema\/person\/75cf706896b7210fb0a84651adc258bd\"},\"headline\":\"Glenmark Pharmaceuticals \u2022 Initial public offering\",\"datePublished\":\"2021-07-27T06:19:21+00:00\",\"dateModified\":\"2021-07-27T09:20:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/\"},\"wordCount\":247,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg\",\"keywords\":[\"Glenmark\",\"Glenmark IPO\",\"Glenmark Life Sciences\",\"Glenmark Life Sciences IPO\",\"Glenmark Life Sciences IPO GMP\"],\"articleSection\":[\"news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/\",\"url\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/\",\"name\":\"Glenmark Pharmaceuticals \u2022 Initial public offering - Seminarsonly.com\",\"isPartOf\":{\"@id\":\"https:\/\/seminarsonly.com\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg\",\"datePublished\":\"2021-07-27T06:19:21+00:00\",\"dateModified\":\"2021-07-27T09:20:18+00:00\",\"author\":{\"@id\":\"https:\/\/seminarsonly.com\/news\/#\/schema\/person\/75cf706896b7210fb0a84651adc258bd\"},\"description\":\"Glenmark Life Sciences share sale consists of a fresh issue of equities worth \u20b91,060 crore and an offer for sale by promoter Glenmark Pharmaceuticals for \u20b9453 crore.\",\"breadcrumb\":{\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#primaryimage\",\"url\":\"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg\",\"contentUrl\":\"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/seminarsonly.com\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glenmark Pharmaceuticals \u2022 Initial public offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/seminarsonly.com\/news\/#website\",\"url\":\"https:\/\/seminarsonly.com\/news\/\",\"name\":\"Seminarsonly.com\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/seminarsonly.com\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/seminarsonly.com\/news\/#\/schema\/person\/75cf706896b7210fb0a84651adc258bd\",\"name\":\"Freddy John\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g\",\"caption\":\"Freddy John\"},\"sameAs\":[\"https:\/\/seminarsonly.com\/news\"],\"url\":\"https:\/\/seminarsonly.com\/news\/author\/anupvnaick_51wq8y4s\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Glenmark Pharmaceuticals \u2022 Initial public offering - Seminarsonly.com","description":"Glenmark Life Sciences share sale consists of a fresh issue of equities worth \u20b91,060 crore and an offer for sale by promoter Glenmark Pharmaceuticals for \u20b9453 crore.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/","og_locale":"en_US","og_type":"article","og_title":"Glenmark Pharmaceuticals \u2022 Initial public offering","og_description":"Glenmark Life Sciences share sale consists of a fresh issue of equities worth \u20b91,060 crore and an offer for sale by promoter Glenmark Pharmaceuticals for \u20b9453 crore.","og_url":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/","og_site_name":"Seminarsonly.com","article_publisher":"https:\/\/facebook.com\/seminarsonly","article_published_time":"2021-07-27T06:19:21+00:00","article_modified_time":"2021-07-27T09:20:18+00:00","og_image":[{"url":"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg","type":"","width":"","height":""}],"author":"Freddy John","twitter_card":"summary_large_image","twitter_creator":"@seminarsonly","twitter_site":"@seminarsonly","twitter_misc":{"Written by":"Freddy John","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#article","isPartOf":{"@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/"},"author":{"name":"Freddy John","@id":"https:\/\/seminarsonly.com\/news\/#\/schema\/person\/75cf706896b7210fb0a84651adc258bd"},"headline":"Glenmark Pharmaceuticals \u2022 Initial public offering","datePublished":"2021-07-27T06:19:21+00:00","dateModified":"2021-07-27T09:20:18+00:00","mainEntityOfPage":{"@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/"},"wordCount":247,"commentCount":0,"image":{"@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg","keywords":["Glenmark","Glenmark IPO","Glenmark Life Sciences","Glenmark Life Sciences IPO","Glenmark Life Sciences IPO GMP"],"articleSection":["news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/","url":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/","name":"Glenmark Pharmaceuticals \u2022 Initial public offering - Seminarsonly.com","isPartOf":{"@id":"https:\/\/seminarsonly.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#primaryimage"},"image":{"@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg","datePublished":"2021-07-27T06:19:21+00:00","dateModified":"2021-07-27T09:20:18+00:00","author":{"@id":"https:\/\/seminarsonly.com\/news\/#\/schema\/person\/75cf706896b7210fb0a84651adc258bd"},"description":"Glenmark Life Sciences share sale consists of a fresh issue of equities worth \u20b91,060 crore and an offer for sale by promoter Glenmark Pharmaceuticals for \u20b9453 crore.","breadcrumb":{"@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#primaryimage","url":"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg","contentUrl":"https:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcQOMVEU0_R-BlIonaWKVCCKtFjl6SbjD6fsfR9EKe3H0Wl-OV8iI3T1JG1QBq0OIlnLm7iEN6JCJQg"},{"@type":"BreadcrumbList","@id":"https:\/\/seminarsonly.com\/news\/glenmark-pharmaceuticals-initial-public-offering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/seminarsonly.com\/news\/"},{"@type":"ListItem","position":2,"name":"Glenmark Pharmaceuticals \u2022 Initial public offering"}]},{"@type":"WebSite","@id":"https:\/\/seminarsonly.com\/news\/#website","url":"https:\/\/seminarsonly.com\/news\/","name":"Seminarsonly.com","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seminarsonly.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/seminarsonly.com\/news\/#\/schema\/person\/75cf706896b7210fb0a84651adc258bd","name":"Freddy John","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/671d452f5fe9027ab894cbed50911cc764b2c16878222070bf044f21705d4c94?s=96&d=mm&r=g","caption":"Freddy John"},"sameAs":["https:\/\/seminarsonly.com\/news"],"url":"https:\/\/seminarsonly.com\/news\/author\/anupvnaick_51wq8y4s\/"}]}},"_links":{"self":[{"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/posts\/7331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/comments?post=7331"}],"version-history":[{"count":0,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/posts\/7331\/revisions"}],"wp:attachment":[{"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/media?parent=7331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/categories?post=7331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seminarsonly.com\/news\/wp-json\/wp\/v2\/tags?post=7331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}